
Shares of GenMark Diagnostics (GNMK) were falling 12.7% lower as of 11:20 a.m. EST on Friday. This drop might be surprising, since the company didn't report any news and stands to benefit as the novel coronavirus outbreak drives sales for its coronavirus test kits.
Full Answer
Why are Glenmark shares going down?
Originally Answered: Why are Glenmark shares going down? Stock market is all about greed and fear, the people who bought after knowing the news will always get trapped and who sold on the news will be the one who will earn the money. Time to time profit booking is as important as investing in the market.
Is Glenmark Life (GLS) stock falling or rising?
Stock is falling and might fall more. Stock is getting in over sold or over bought zones very quickly. A short reversal can happen anytime. Stock of Glenmark Life (GLS) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
Is Glenmark Pharmaceuticals'intraday gains higher than 5%?
Glenmark Pharmaceutical... In the last 17 years, only 2.84 % trading sessions saw intraday gains higher than 5 % . Company has spent 3.23% of its operating revenues towards interest expenses and 21.42% towards employee cost in the year ending 31 Mar, 2021.
How did Glenmark Life Sciences’ share price perform ahead of IPO?
Glenmark Life Sciences had allotted 63,06,660 equity shares to 19 anchor investors at Rs 720 a share, aggregating to Rs 454 crore, ahead of its initial public offering (IPO). Glenmark Life Sciences’ share price declined over three percent on Thursday as the 30-day lock-in period for the company’s anchor investors ended.
See more

Why did Glenmark shares fall?
Glenmark Pharmaceuticals share price fell over 3 percent intraday to Rs 516.45 on November 16 after foreign broking house Morgan Stanley kept "underweight" rating on the stock with the target at Rs 554.
Is it good to buy Glenmark shares?
Glenmark Pharmaceuticals Ltd is quoting at Rs 470.85, up 2.3% on the day as on 12:54 IST on the NSE. The stock is down 7.25% in last one year as compared to a 22.63% jump in NIFTY and a 10.4% jump in the Nifty Pharma index.
Will Glenmark shares go up?
If this Munafa value is near or nearing 100, then this stock might show an upward movement....Munafa value: 50 as on 27 Mon Jun 2022.Upside target394.27Upside target390.03Upside target388.43Upside target387.17Downside target382.935 more rows
Is Glenmark good for long term investment?
Glenmark Pharma has been a listed stock for over 20 years and has a reputation for delivering solid long term returns. The Glenmark Life Sciences IPO provides an opportunity to participate in the high-growth API segment, which is expected to grow at 8.5% CAGR over next 5 years.
Is Glenmark undervalued?
GLENMARK is one of the potential top 23% undervalued companies !
Is Glenmark a good company?
Glenmark Pharmaceuticals is rated 4.2 out of 5, based on 1.8k reviews by employees on AmbitionBox. Glenmark Pharmaceuticals is known for Skill development which is rated at the top and given a rating of 4.0. However, Work-Life balance is rated the lowest at 3.7 and can be improved.
What is the target price of Glenmark share?
Target price: Rs 179 per share | Rally: 17%
What happened to Glenmark?
"Glenmark's U.S. business was impacted by stoppage of Ranitidine and a sharp decline in the dermatology portfolio," ICICI Direct wrote in a post earnings note. "Reduction of debt, improvement in free cash flow and margins will be the key events to watch," the note said.
What will be the share price of Glenmark?
ComparisionFinancials( ₹ in Cr)CiplaGlenmark Pharma.PE TTM29.7210.121 Year Return0.67-37.53ROCE11.6714.75ROE10.3314.775 more rows
Is it worth to invest in Glenmark IPO?
Vinit Bolinjkar, Head of Research, Ventura Securities, also recommends subscribing to the Glenmark Life IPO for long-term investing. "Our target price of Rs 1,039 (18x FY24 earnings) represents a potential upside of 44 percent from the offer price of Rs 720 over a period of 18-24 months," he said.
Is it good to buy Glenmark IPO?
"Glenmark Life has a good performance execution and clean regulatory track record. The growth momentum also has a strong undercurrent of global API industry growth," said ICICI Securities which recommended subscribe to the issue.
Is Glenmark IPO oversubscribed?
As of 1:10 pm on its final day of bidding, Glenmark Life IPO has been oversubscribed over 14 times. Retail portion has been booked 12 times whereas non-institutional investors (NIIs) 32 times and Qualified Institutional Buyers (QIBs) 4 times.
What's the Glenmark Life share price today?
Glenmark Life share price was Rs 466.65 as on 10 Jun, 2022, 03:50 PM IST. Glenmark Life share price was down by 0.11% based on previous share price...
What's the market capitalization of Glenmark Life?
Within the Pharmaceuticals sector, Glenmark Life stock has a market cap rank of 33. Glenmark Life has a market cap of Rs 5,717.73 Cr.
What is 52 week high/low of Glenmark Life share price?
Glenmark Life share price saw a 52 week high of Rs 799.00 and 52 week low of Rs 410.00.
How can I quickly analyze Glenmark Life stock?
Glenmark Life share can be quickly analyzed on following metrics: Stock's PE is 13.66 Price to Book Ratio of 2.79 EPS (trailing 12 month) of Glenma...
Who are peers to compare Glenmark Life share price?
Top 10 Peers for Glenmark Life are Sun Pharma Advanced Research Company Ltd., Caplin Point Laboratories Ltd., Jubilant Pharmova Ltd., Granules Indi...
What is Glenmark Pharma share price and what are the returns for Glenmark Pharma share?
Glenmark Pharma share price was Rs 388.45 as on 10 Jun, 2022, 03:56 PM IST. Glenmark Pharma share price was down by 1.81% based on previous share p...
Who are peers to compare Glenmark Pharma share price?
Within Pharmaceuticals sector Glenmark Pharma, J B Chemicals & Pharmaceuticals Ltd., Suven Pharmaceuticals Ltd., Eris Lifesciences Ltd., Natco Phar...
What's the market capitalization of Glenmark Pharma?
Glenmark Pharma share has a market capitalization of Rs 10,960.82 Cr. Within Pharmaceuticals sector, it's market cap rank is 25.
What has been highest price of Glenmark Pharma share in last 52 weeks?
Glenmark Pharma share price saw a 52 week high of Rs 690.95 and 52 week low of Rs 375.00.
How can I quickly analyze Glenmark Pharma stock?
Glenmark Pharma share can be quickly analyzed on following metrics: Stock's PE is 11.43 Price to Book Ratio of 1.18 Dividend Yield of 0.64 EPS (tra...
Who are the key owners of Glenmark Pharma stock?
Promoter holding has gone up from 46.63 (30 Jun 2021) to 46.65 (31 Mar 2022) Domestic Institutional Investors holding has gone up from 4.99 (30 Jun...
What is a stock score?
Stock Score is the Average Score from Stock Reports Plus by Refinitiv which combines quantitative analysis of widely used investment decision making tools. This score is on a 10 point scale (1 is lowest and 10 being the highest, NR indicates No-rating is available)
What is TTM in stock?
Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.
How many stocks can you access with ET Prime?
You can access 4000+ Stock Reports with ET Prime. Know More
What is Glenmark Pharmaceuticals?
Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 18,772.65 Crore) operating in Pharmaceuticals sector. Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2020.
What is a stock score?
Stock Score is the Average Score from Stock Reports Plus by Refinitiv which combines quantitative analysis of widely used investment decision making tools. This score is on a 10 point scale (1 is lowest and 10 being the highest, NR indicates No-rating is available)
What is TTM in stock?
Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.
How many stocks can you access with ET Prime?
You can access 4000+ Stock Reports with ET Prime. Know More
What is dividend yield?
Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors.
GLS Glenmark Life is falling or rising technical reasons
Technical analysis forecast for Glenmark Life Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Glenmark Life GLS at this time. Stock is falling and might fall more.
GLS Glenmark Life is falling or rising NEWS fundamental reasons
Company Announcement Glenmark Life Sciences Limited has informed the Exchange about Investor Presentation - NEWS as on 2022-02-09
When will Glenmark Pharmaceuticals launch Vildagliptin?
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 26, 2021, titled "Glenmark becomes the first company to launch Remogliflozin + Vildagliptin + - NEWS as on 2021-10-26
What does it mean when a stock is closing in?
Stock is slowly closing in and getting inside a small range. This happens when a stock is near a support or a resistance. Wait for a breakout or a breakdown depending on its trend.
When is Glenmark's 2021 general meeting?
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2021. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. - NEWS as on 2021-09-27
Is Glenmark Pharmaceuticals in a short or long term uptrend?
Technical analysis forecast of Glenmark Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Glenmark Pharmaceuticals GLENMARK at this time. Stock is rising and might rise more.
Is Glenmark Pharmaceuticals bullish?
My analysis of Glenmark Pharmaceuticals is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 527.2 as stoploss in an intra day sell trade for a target of 515.78. However, stock will show a bullish move above 527.2.
